UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report: January 13, 2014
(Date of earliest event reported)
TENET HEALTHCARE CORPORATION
(Exact name of Registrant as specified in its charter)
|
Nevada |
|
1-7293 |
|
95-2557091 |
|
(State of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer |
|
|
|
|
|
Identification Number) |
1445 Ross Avenue, Suite 1400
Dallas, Texas 75202
(Address of principal executive offices, including zip code)
(469) 893-2200
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition.
The discussion set forth in Item 7.01 herein, including the information incorporated from Exhibit 99.1 hereto, is incorporated herein by reference.
Item 7.01 Regulation FD Disclosure.
As previously announced, Tenet Healthcare Corporation will participate in the J.P. Morgan Annual Healthcare Conference on January 13, 2014 at approximately 11:30 a.m. Eastern Time. Tenet’s presentation will be available live by webcast and may be accessed through the investor relations section of Tenet’s website at www.tenethealth.com/investors. A replay of Tenet’s presentation will be available on Tenet’s website for approximately 30 days after the conference. A copy of the slide presentation to be used at the conference, including the Company’s cautionary statements regarding the use of forward looking information, is attached to this report as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
|
99.1 |
|
Slide Presentation dated January 13, 2014 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
TENET HEALTHCARE CORPORATION | ||
|
|
| ||
|
|
| ||
|
|
By: |
/s/ Daniel J. Cancelmi | |
|
|
|
Daniel J. Cancelmi | |
|
|
|
Chief Financial Officer | |
|
|
| ||
|
|
| ||
|
Date: |
January 13, 2014 |
| |